| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/07/2007 | EP1759698A1 Novel method of treatment |
| 03/07/2007 | EP1759694A2 Combinations of DMXAA and other anti-cancer agents |
| 03/07/2007 | EP1758915A2 Composition and method for inhibiting platelet aggregation |
| 03/07/2007 | EP1758653A2 Treatments comprising strontium for rheumatic and arthritic diseases and pain |
| 03/07/2007 | EP1758640A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 03/07/2007 | EP1758611A2 Use of liver-selective glucokinase activators |
| 03/07/2007 | EP1758604A2 Method for improved breast milk feeding to reduce the risk of allergy |
| 03/07/2007 | EP1758600A1 Methods and compositions for treating mood disorder |
| 03/07/2007 | EP1758597A1 Use of drug combinations for treating insulin resistance |
| 03/07/2007 | EP1758574A1 Pharmaceutical compositions containing polyunsaturated fatty acid and at least one of an immunosuppressive agent or an antineoplastic agent |
| 03/07/2007 | EP1758564A2 Synergistic methods and compositions for treating cancer |
| 03/07/2007 | EP1758554A1 Soluble strip for oral or topical adminstration |
| 03/07/2007 | EP1758532A2 Topical preparation and method for transdermal delivery and localization of therapeutic agents |
| 03/07/2007 | EP1758469A2 Improvement of barrier integrarity in hiv patients by use of fatty acids |
| 03/07/2007 | EP1628673B1 Pharmaceutical compositions comprising an extract of euphorbia prostrata |
| 03/07/2007 | EP1562615A4 Oral and dental composition |
| 03/07/2007 | EP1531842A4 Regulation of cell growth by muc1 |
| 03/07/2007 | EP1490097B1 Use of botulinum toxin for treating cardiovascular diseases |
| 03/07/2007 | EP1478355B1 Antitumor compositions containing taxane derivatives |
| 03/07/2007 | EP1430152B1 Gene and protein relating to hepatocellular carcinoma |
| 03/07/2007 | EP1427411B1 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo [3.1.0] hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 03/07/2007 | EP1327149A4 Methods of high-throughput screening for internalizing antibodies |
| 03/07/2007 | EP1307232B1 Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
| 03/07/2007 | EP1255544B1 Mucin synthesis inhibitors |
| 03/07/2007 | EP1194528B1 Monoclonal antibody for factor VIII, which even when present in molar excess inactivates factor VIII only in part and a method for producing such an antibody |
| 03/07/2007 | EP1061922B9 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 03/07/2007 | EP1001970B1 Dipeptide derivatives as growth hormone secretagogues |
| 03/07/2007 | EP0996444B1 Treatment of diabetes with thiazolidinedione and metformin |
| 03/07/2007 | EP0585242B2 Wound healing |
| 03/07/2007 | CN1925872A Method of preventing ultraviolet ray-induced apoptosis |
| 03/07/2007 | CN1925849A Pharmaceutical composition for inhibiting cognition hypofunction |
| 03/07/2007 | CN1925843A Methods and compositions for the production of monoclonal antibodies |
| 03/07/2007 | CN1923286A Anticancer slow release agent of anticancer antibiotics and its progression agent |
| 03/07/2007 | CN1923285A Injectable sterile pharmaceutical formulation containing at least two active principles |
| 03/07/2007 | CN1923284A Anti-cancer drug slow release injection and uses thereof |
| 03/07/2007 | CN1923283A Anti-cancer drug slow release injection and uses thereof |
| 03/07/2007 | CN1923282A Anti-cancer slow release injection comprising hormone drug |
| 03/07/2007 | CN1923281A Anti-cancer slow release injection comprising plant alkaloid |
| 03/07/2007 | CN1923280A Anti-cancer slow release injection containing dichloroethylaminum |
| 03/07/2007 | CN1923189A Taxine kind anti-cancer slow release injection |
| 03/07/2007 | CN1923187A Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 03/07/2007 | CN1923175A Slow release injection comprising anticancer antibiotics and booster thereof |
| 03/07/2007 | CN1923174A Anti-cancer slow release injection comprising anticancer antibiotics |
| 03/07/2007 | CN1923173A Anti-cancer drugs slow release agent comprising anticancer antibiotics and booster thereof |
| 03/07/2007 | CN1923172A Drug slow release agent comprising anticancer antibiotics and booster thereof |
| 03/07/2007 | CN1923171A Compound recipe anti-cancer drugs slow release agent comprising anticancer antibiotics and booster thereof |
| 03/07/2007 | CN1923167A Slow release injection and its preparing process and application |
| 03/07/2007 | CN1303084C New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents |
| 03/07/2007 | CN1302812C Transmission system of medicine containing trehalose and hyaluronic acid for eye part and its preparation method |
| 03/07/2007 | CN1302810C Optic nerve protecting agents containing alpha1 receptor blocker as the active ingredient |
| 03/07/2007 | CN1302783C Oral taking preparation for aesthetic health care and preparation method |
| 03/07/2007 | CN1302780C Use of alkyl phosphocholines in preparation of medicine used with antitumor medicaments |
| 03/07/2007 | CN1302777C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 03/06/2007 | US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 03/06/2007 | US7186833 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 03/06/2007 | US7186826 Phosphorus-containing compounds and uses thereof |
| 03/06/2007 | US7186803 Human vanilloid receptor VR3 protein |
| 03/06/2007 | US7186802 Membrane proteins; for treatment of inflammation, asthma, allergy, metastasis of cancer cells, ion transport disorders such as magnesium defects in the kidney, and inflammatory bowel disease |
| 03/06/2007 | US7186798 Derived from ghrelin polypeptide, labelled with fluorochrome and cysteine; drug screening; high throughput assay |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | US7186715 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 03/06/2007 | US7186703 Derivatives of branched-chain lipophilic molecules and uses thereof |
| 03/06/2007 | US7186700 Administering a beta -L-2'-deoxynucleoside or its pharmaceutically acceptable salt, ester or prodrug therapy of a host infected with a drug-resistant form of HBV that exhibits a mutation at the 552 codon from methionine to valine in the DNA polymerase region |
| 03/06/2007 | US7186681 Methods of modulating cell migration using galectin-3 |
| 03/06/2007 | US7186418 Composition and use of RAR antagonists for promoting chondrogenesis |
| 03/06/2007 | US7186415 Cosmetics; dermatology; boron nitride particles coated with polydimethylsiloxane |
| 03/06/2007 | US7186413 Hydrogels and water soluble polymeric carriers for drug delivery |
| 03/06/2007 | US7186407 Including claudication and critical limb ischemia, by administering fibroblast growth factor (FGF) in two doses, a single dose administered into each leg of the patient within one hour |
| 03/06/2007 | CA2355313C Controlled-release biocompatible ocular drug delivery implant devices and methods |
| 03/06/2007 | CA2353847C Pulmonary drug delivery |
| 03/06/2007 | CA2277913C New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
| 03/06/2007 | CA2252110C 5-androstene 3.beta.,17.alpha. diol as an inhibitor of tumor growth |
| 03/06/2007 | CA2128142C Pharmaceutical combination containing ras inhibitor and endothelin antagonist for the treatment of cardiovascular disorders |
| 03/01/2007 | WO2007024673A1 Use of ranodine receptor antagonists to trat amotrophic lateral scerosis |
| 03/01/2007 | WO2007023930A1 Brain-migrating cell and use thereof |
| 03/01/2007 | WO2007023880A1 Chemokine production inhibitor |
| 03/01/2007 | WO2007023841A1 Hair growth agent composition |
| 03/01/2007 | WO2007023778A1 Novel anticancer concomitant drug |
| 03/01/2007 | WO2007023775A1 Therapeutic agent for atrial fibrillation |
| 03/01/2007 | WO2007023754A1 DRUG CONTAINING FBPase INHIBITOR |
| 03/01/2007 | WO2006129193A3 Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss |
| 03/01/2007 | WO2006085219A3 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy |
| 03/01/2007 | WO2006067823A3 Pharmaceutical composition comprising nifedipine and mesalazine for the treatment of rectoanal tenesmus |
| 03/01/2007 | WO2006042249A3 Methods and compositions for treating migraine pain |
| 03/01/2007 | WO2006031922A3 Thyroid hormone analogs for promoting angiogenesis |
| 03/01/2007 | WO2005105098A3 Preparation for the treatment of cancer |
| 03/01/2007 | WO2004100939B1 Combination of the analeptic modafinil and an antidepressant for the treatment of depression |
| 03/01/2007 | US20070049607 Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists |
| 03/01/2007 | US20070049599 Use of bh4 for the treatment of respiratory diseases |
| 03/01/2007 | US20070049566 Methods and Compositions for inhibition of angiogenesis |
| 03/01/2007 | US20070049544 Antisense IAP nucleobase oligomers and uses thereof |
| 03/01/2007 | US20070049531 GLP-1 agonist and cardiovascular complations |
| 03/01/2007 | US20070049516 Use of Insulin for the Treatment of Cartilaginous Disorders |
| 03/01/2007 | US20070049515 Therapeutic agent for diabetes containing insulin resistance improving agent |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048809 Using monoclonal antibody NUH2 as diagnositic tool in identifying cell proliferative disorders of urogenital system in individual negative for prostate specific antigen |
| 03/01/2007 | US20070048804 Methods of detecting cytokine receptor zcytor19 ligand |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048782 Methods for assessing and treating leukemia |